Ozdemir, Cevdet http://orcid.org/0000-0002-9284-4520
Kucuksezer, Umut Can http://orcid.org/0000-0002-5358-5570
Ogulur, Ismail http://orcid.org/0000-0001-8282-7762
Pat, Yagiz http://orcid.org/0000-0003-4268-4933
Yazici, Duygu http://orcid.org/0000-0001-9094-6542
Ardicli, Sena http://orcid.org/0000-0003-2758-5945
Akdis, Mubeccel http://orcid.org/0000-0003-0554-9943
Nadeau, Kari http://orcid.org/0000-0002-2146-2955
Akdis, Cezmi A. http://orcid.org/0000-0001-8020-019X
Funding for this research was provided by:
Istanbul University
Article History
Accepted: 2 May 2024
First Online: 17 June 2024
Declarations
:
: Dr. Kari Nadeau reports grants from National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI, and from National Institute of Environmental Health Sciences (NIEHS); other from Immune Tolerance Network (ITN), other from National Institutes of Health (NIH) clinical research centers, during the conduct of the study; other from IgGenix, other from Seed Health, other from ClostraBio, other from Cour, other from Alladapt, other from Excellergy, other from Red tree ventures, other from Regeneron, other from Latitude, outside the submitted work; In addition, Dr. Nadeau has the following patents, "Mixed allergen composition and methods for using the same", "Granulocyte-based methods for detecting and monitoring immune system disorders", and"Methods and Assays for Detecting and Quantifying Pure Subpopulations of White Blood Cells in Immune System Disorders".Dr. Mubeccel Akdis reports grants from Swiss National science Foundation, Bern, grants from The Stanford University, grants from Leading House for the Latin American Region, other from Stanford University-Sean Parker Asthma Allergy Center, CA, other from LEO Foundation Skin Immunology Research Center, Kopenhagen, other from World allergy Congress (WAC) Istanbul, 2022, other from EAACI, during the conduct of the study.Dr. Cezmi Akdis reports grants from Swiss National Science Foundation, European Union (EU CURE, EU Syn-Air-G), grants from Novartis Research Institutes (Basel, Switzerland), grants from Stanford University (Redwood City, Calif), grants from Seed Health (Boston, USA), grants from SciBase (Stockholm, Sweden), other from EAACI Guidelines on Environmental Science in Allergic diseases and Asthma, other from The EAACI Epithelial Cell Biology Working Group is on the Advisory Boards of Sanofi/Regeneron (Bern, Switzerland, New York, USA), Stanford University Sean Parker Asthma Allergy Center (CA, USA), Novartis (Basel, Switzerland), Glaxo Smith Kline (Zurich, Switzerland), Bristol-Myers Squibb (New York, USA), Seed Health (Boston, USA) and SciBase (Stockholm, Sweden), other from The Editor-in-Chief Allergy, during the conduct of the study.The remaining authors have nothing to declare in relation with this study.
: This article does not contain any studies with human or animal subjects performed by any of the authors.